201 related articles for article (PubMed ID: 8417157)
1. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.
Brouillet E; Jenkins BG; Hyman BT; Ferrante RJ; Kowall NW; Srivastava R; Roy DS; Rosen BR; Beal MF
J Neurochem; 1993 Jan; 60(1):356-9. PubMed ID: 8417157
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
Beal MF; Brouillet E; Jenkins B; Henshaw R; Rosen B; Hyman BT
J Neurochem; 1993 Sep; 61(3):1147-50. PubMed ID: 7689641
[TBL] [Abstract][Full Text] [Related]
4. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
5. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Brouillet E; Hyman BT; Jenkins BG; Henshaw DR; Schulz JB; Sodhi P; Rosen BR; Beal MF
Exp Neurol; 1994 Oct; 129(2):175-82. PubMed ID: 7525331
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
Kodsi MH; Swerdlow NR
Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
[TBL] [Abstract][Full Text] [Related]
7. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
[TBL] [Abstract][Full Text] [Related]
8. Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization.
Tsai MJ; Goh CC; Wan YL; Chang C
Neuroscience; 1997 Aug; 79(3):819-26. PubMed ID: 9219944
[TBL] [Abstract][Full Text] [Related]
9. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo.
Schulz JB; Matthews RT; Jenkins BG; Ferrante RJ; Siwek D; Henshaw DR; Cipolloni PB; Mecocci P; Kowall NW; Rosen BR
J Neurosci; 1995 Dec; 15(12):8419-29. PubMed ID: 8613773
[TBL] [Abstract][Full Text] [Related]
10. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.
Brouillet E; Hantraye P; Ferrante RJ; Dolan R; Leroy-Willig A; Kowall NW; Beal MF
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7105-9. PubMed ID: 7624378
[TBL] [Abstract][Full Text] [Related]
11. Extracellular perfusion of rat brain nuclei using microdialysis: a method for studying differential neurotransmitter release in response to neurotoxins.
Reynolds NC; Lin W; Cameron CM; Roerig DL
Brain Res Brain Res Protoc; 1999 Jul; 4(2):124-31. PubMed ID: 10446406
[TBL] [Abstract][Full Text] [Related]
12. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
Sun Z; Xie J; Reiner A
Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
[TBL] [Abstract][Full Text] [Related]
13. Age dependence of striatal neuronal death caused by mitochondrial dysfunction.
Bossi SR; Simpson JR; Isacson O
Neuroreport; 1993 Jan; 4(1):73-6. PubMed ID: 8453041
[TBL] [Abstract][Full Text] [Related]
14. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.
Maragos WF; Tillman PA; Chesnut MD; Jakel RJ
Brain Res; 1999 Jul; 834(1-2):168-72. PubMed ID: 10407109
[TBL] [Abstract][Full Text] [Related]
15. Neurochemistry and toxin models in Huntington's disease.
Beal MF
Curr Opin Neurol; 1994 Dec; 7(6):542-7. PubMed ID: 7866587
[TBL] [Abstract][Full Text] [Related]
16. The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.
Vis JC; Verbeek MM; de Waal RM; ten Donkelaar HJ; Kremer B
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):68-76. PubMed ID: 11299004
[TBL] [Abstract][Full Text] [Related]
17. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease.
Bogdanov MB; Ferrante RJ; Kuemmerle S; Klivenyi P; Beal MF
J Neurochem; 1998 Dec; 71(6):2642-4. PubMed ID: 9832167
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?
Del Río P; Montiel T; Chagoya V; Massieu L
Neuroscience; 2007 Jun; 146(4):1561-70. PubMed ID: 17490821
[TBL] [Abstract][Full Text] [Related]
19. Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity.
Hickey MA; Morton AJ
J Neurochem; 2000 Nov; 75(5):2163-71. PubMed ID: 11032906
[TBL] [Abstract][Full Text] [Related]
20. In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins.
Mendoza E; Miranda-Barrientos JA; Vázquez-Roque RA; Morales-Herrera E; Ruelas A; De la Rosa G; Flores G; Hernández-Echeagaray E
Neuroscience; 2014 Nov; 280():156-70. PubMed ID: 25241069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
